Application Of Asco Value Framework Evaluations Of Net Health Benefit For Oncology Drugs Launched In The United States Between 2013 And 2015
Abstract
Authors
J Li A Asabere S Kelly Y Cho D Dua A Bastian
J Li A Asabere S Kelly Y Cho D Dua A Bastian
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now